If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr Elizabeth Moore is Research Fellow and Project Manager of the Myeloma and Related Diseases Registry (MRDR) with the Transfusion Research Unit, SPHPM; she has been instrumental in the growth and increasing productivity of the registry.

Elizabeth completed a critical care-related post-doctoral Research Fellowship with the Australian and New Zealand Intensive Care (ANZIC) Research Centre where she conducted her PhD investigating potential treatments for, and early markers of acute kidney injury in patients with traumatic brain injury. This involved conducting the Renal Substudies of the EPO-TBI and POLAR multicentre clinical trials. Elizabeth has completed a biostatistics/epidemiology streamed Master of Public Health, has extensive experience as a critical care nurse, has worked as Research Coordinator in the Royal Melbourne Hospital ICU and Victorian Infectious Diseases Service, managed the ANTISEPSIS substudy of the ASPREE trial, and is a member of the Research Advisory Panel of the Australian College of Critical Care Nurses (ACCCN).

Elizabeth has led the My-PROMPT trial, a randomised controlled trial to test the feasibility of real-time reporting of patient-reported outcomes in patients with multiple myeloma to treating clinicians, and is involved in numerous MRDR research projects http://www.mrdr.net.au/projects/ including the IMPROVE study.

Research Projects

Myeloma and Related Diseases Registry   http://www.mrdr.net.au/

My-PROMPT: Patient Reported Outcome Measures in multiple myeloma: real-time rePorTing to improve care   http://www.mrdr.net.au/projects/

IMPROVE: Immunoglobulins in Myeloma Patients: Research into Outcomes, Variation in practice, and Epidemiology   http://www.mrdr.net.au/projects/

Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR)   https://apacmrdr.org/

Education/Academic qualification

PhD, MONASH UNIVERSITY

MPH, University of Melbourne

PGDipNurs (Crit Care), University of Melbourne

Research area keywords

  • Myeloma
  • Registries
  • Cancer
  • Patient-reported outcomes
  • Clinical trials
  • Quality Of Life
  • Haematology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2020

Research Output 2009 2019

1 Citation (Scopus)

Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial

Skrifvars, M. B., Moore, E., Mårtensson, J., Bailey, M., French, C., Presneill, J., Nichol, A., Little, L., Duranteau, J., Huet, O., Haddad, S., Arabi, Y., McArthur, C., Cooper, D. J., Bellomo, R. & The EPO-TBI Investigators and the ANZICS Clinical Trials Group, Feb 2019, In : Acta Anaesthesiologica Scandinavica. 63, 2, p. 200-207 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal impairment at diagnosis in myeloma: Patient characteristics, treatment, and impact on outcomes. Results from the Australia and New Zealand Myeloma and Related Diseases Registry

Ho, P. J., Moore, E. M., McQuilten, Z. K., Wellard, C., Bergin, K., Augustson, B., Blacklock, H., Harrison, S. J., Horvath, N., King, T., Mollee, P., Quach, H., Reid, C., Rosengarten, B., Walker, P., Wood, E. M. & Spencer, A., 16 May 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia. 10 p.

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

A novel immune biomarker IFI27 discriminates between influenza and bacteria in patients with suspected respiratory infection

Tang, B. M., Shojaei, M., Parnell, G. P., Huang, S., Nalos, M., Teoh, S., O'Connor, K., Schibeci, S., Phu, A. L., Kumar, A., Ho, J., Meyers, A. F. A., Keynan, Y., Ball, T., Pisipati, A., Kumar, A., Moore, E., Eisen, D., Lai, K., Gillett, M. & 8 others, Geffers, R., Luo, H., Gul, F., Schreiber, J., Riedel, S., Booth, D., McLean, A. & Schughart, K., 1 Jun 2017, In : The European respiratory journal. 49, 6, 12 p., 1602098.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
15 Citations (Scopus)

AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol

Eisen, D. P., Moore, E. M., Leder, K., Lockery, J., McBryde, E. S., McNeil, J. J., Pilcher, D., Wolfe, R. & Woods, R. L., 1 Jan 2017, In : BMJ Open. 7, 1, e013636.

Research output: Contribution to journalArticleOtherpeer-review

Open Access
File
12 Citations (Scopus)

Myeloma in the real world: What is really happening?

Bergin, K., McQuilten, Z., Moore, E., Wood, E. & Spencer, A., 1 Mar 2017, In : Clinical Lymphoma, Myeloma & Leukemia. 17, 3, p. 133-144.e1 13 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Prizes

Snowdome Foundation - Haematology Nurse Myeloma Travel Grant $2500

Elizabeth Moore (Recipient), 23 Oct 2018

Prize: Prize (including medals and awards)

Activities 2015 2019

  • 5 Contribution to conference
  • 3 Contribution to workshop, seminar, course

International Myeloma Workshop 2019

Elizabeth Moore (Speaker)
12 Sep 201915 Sep 2019

Activity: Participating in or organising an event typesContribution to conference

Myeloma UK Patient Registry Stakeholder Workshop

Elizabeth Moore (Invited speaker)
10 Apr 2019

Activity: Participating in or organising an event typesContribution to workshop, seminar, course

Blood 2019

Elizabeth Moore (Speaker)
20 Oct 201923 Oct 2019

Activity: Participating in or organising an event typesContribution to conference

Myeloma Registries: Denmark and ANZ

Elizabeth Moore (Invited speaker)
11 Jul 2018

Activity: Participating in or organising an event typesContribution to workshop, seminar, course

Clinical Registries Summit

Elizabeth Moore (Invited speaker)
26 Nov 2018

Activity: Participating in or organising an event typesContribution to conference